The painful stiff shoulder is a common reason for referral to a rheumatology clinic. 1 It is more common in general practice.2 There is no current consensus in favour of one form of treatment, and several different therapeutic regimens are used. This suggests there is no major advantage with any single treatment. In view of the prevalence of such shoulder problems it is important to determine the most cost effective remedy. We compared local steroids, physiotherapy, or a combination of the two in the treatment of the painful stiff shoulder and evaluated their costs and efficacy in a prospective randomised observer-blind trial. This is an evaluation of treatment as an exercise in medical audit.
Patients and methods
Sixty six consecutive patients with a clinical diagnoAccepted for publication 13 Results were recorded on a standard proforma and analysed by Student's paired t tests and the Mann-Whitney U test for non-parametric datathat is, pain scores.
Results
All treatment groups showed significant reductions in pain after six weeks (p<0001 in all groups).
There were further improvements at six months. Mean measures of pain improved by 49-66% at six weeks and by 57-86% at six months. There were increases in shoulder movement on the affected side by six weeks. There were further increases in movements by six months: mean measures of movement improved by between 11 and 31% at six weeks and by between 10 and 34% at six months. There were no changes in movement on the non-affected side. Figure 1 shows examples of the changes.
The improvements in pain scores and the degree of movement were similar in all three treatment groups. For example, pain on active movement improved by means of between 53 and 58% after six weeks and by 62-78% at six months in the three groups. Similarly, total abduction improved by means of between 10 and 11% after six weeks and by 15-23% at six months in the three groups. No treatment showed any advantage which was clinically relevant and significant at the 5% level.
The costs of treatment varied substantially. An injection of triamcinolone around a shoulder cost £2-10. The main component was £180 for 20 mg triamcinolone. The mean cost of a six week course of physiotherapy was £48-50 for each patient. Combination treatment cost £50*60.
Discussion
Patients treated with physiotherapy, steroid injection, or a combination all had less pain and showed improved movement at six weeks and six months. There were no consistent differences between the treatment groups. There was no evidence of a type II statistical error. Our findings agree with other studies comparing different treatment strategies for the painful stiff shoulder. Bulgen et al showed that there was little long term advantage in using intra-articular steroids, mobilisations, ice therapy, or no treatment; but steroid injections benefited pain and range of movement in the early stages. 3 Lee et al found no advantage in steroid injection plus physiotherapy against heat and physiotherapy. 4 Berry et al showed no difference between steroid injection, acupuncture, and placebo.5 Richardson showed no difference in pain relief or pain on resisted movement after treatment with steroids or placebo.6 There was no evidence for any additive effect when steroids were given with physiotherapy. This implies that improvement cannot be maximised above a certain level.
None of our patients had an adverse reaction to either local injections or physiotherapy. Occasionally, ruptured tendons or infections can occur after local steroids. These are so uncommon that a formal risk-benefit analysis is impossible. Problems after physiotherapy are even less common.
Difficulties in establishing the ideal treatment may be related to imprecise diagnoses. These will remain until the pathogenesis of the shoulder and its related conditions have been better defined. Our patients were less severely involved than those described by Bulgen et 
